Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr1i2
|
ENSMUSG00000022809.4 | nuclear receptor subfamily 1, group I, member 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr16_38288968_38289121 | Nr1i2 | 5780 | 0.154688 | 0.51 | 5.8e-05 | Click! |
chr16_38286740_38286933 | Nr1i2 | 7988 | 0.147532 | 0.50 | 9.9e-05 | Click! |
chr16_38295682_38295864 | Nr1i2 | 949 | 0.475573 | 0.50 | 1.0e-04 | Click! |
chr16_38287754_38288077 | Nr1i2 | 6909 | 0.150239 | 0.48 | 2.3e-04 | Click! |
chr16_38295105_38295268 | Nr1i2 | 362 | 0.824646 | 0.47 | 3.2e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14351950_14353283 | 21.87 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr4_11147788_11148157 | 9.85 |
Gm11830 |
predicted gene 11830 |
3262 |
0.15 |
chr10_127508848_127510720 | 9.58 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr14_32146198_32146521 | 9.57 |
Msmb |
beta-microseminoprotein |
1228 |
0.33 |
chr6_84640633_84641008 | 9.04 |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
46912 |
0.17 |
chr12_72535708_72536908 | 8.91 |
Pcnx4 |
pecanex homolog 4 |
75 |
0.97 |
chr3_65658208_65659857 | 8.69 |
Mir8120 |
microRNA 8120 |
256 |
0.89 |
chr6_52163698_52164573 | 8.16 |
Hoxa2 |
homeobox A2 |
696 |
0.33 |
chr8_94363976_94364322 | 8.13 |
Slc12a3 |
solute carrier family 12, member 3 |
7838 |
0.1 |
chr17_34898151_34899707 | 7.84 |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
25 |
0.87 |
chr8_125910003_125910420 | 7.83 |
Map3k21 |
mitogen-activated protein kinase kinase kinase 21 |
239 |
0.92 |
chr16_34047647_34047931 | 7.49 |
Kalrn |
kalirin, RhoGEF kinase |
31295 |
0.17 |
chr15_76114723_76114988 | 7.12 |
Eppk1 |
epiplakin 1 |
5340 |
0.09 |
chr11_5505810_5506157 | 6.94 |
Gm11963 |
predicted gene 11963 |
7143 |
0.14 |
chr9_65826224_65827697 | 6.94 |
Zfp609 |
zinc finger protein 609 |
604 |
0.65 |
chr11_53308939_53309276 | 6.86 |
Hspa4 |
heat shock protein 4 |
8650 |
0.14 |
chr16_17345888_17346201 | 6.76 |
Gm24927 |
predicted gene, 24927 |
4032 |
0.14 |
chr14_14354416_14355184 | 6.69 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chr13_43480925_43481874 | 6.43 |
Ranbp9 |
RAN binding protein 9 |
117 |
0.95 |
chr19_38191474_38191796 | 6.28 |
Fra10ac1 |
FRA10AC1 homolog (human) |
32503 |
0.13 |
chr14_45453170_45453373 | 6.18 |
Gm34250 |
predicted gene, 34250 |
6198 |
0.13 |
chr4_86663881_86664281 | 6.13 |
Plin2 |
perilipin 2 |
1644 |
0.36 |
chr13_43231981_43232458 | 6.13 |
Tbc1d7 |
TBC1 domain family, member 7 |
60718 |
0.11 |
chr3_144198270_144199266 | 6.12 |
Gm43445 |
predicted gene 43445 |
494 |
0.79 |
chr11_54860143_54861186 | 6.07 |
Lyrm7 |
LYR motif containing 7 |
55 |
0.96 |
chr2_22587496_22588353 | 6.07 |
Gm13341 |
predicted gene 13341 |
38 |
0.95 |
chr18_68230014_68230186 | 6.03 |
Ldlrad4 |
low density lipoprotein receptor class A domain containing 4 |
2033 |
0.32 |
chr5_36574661_36574853 | 5.91 |
Tbc1d14 |
TBC1 domain family, member 14 |
432 |
0.8 |
chr8_11473087_11473664 | 5.71 |
E230013L22Rik |
RIKEN cDNA E230013L22 gene |
4554 |
0.13 |
chr4_86902458_86902781 | 5.67 |
Acer2 |
alkaline ceramidase 2 |
28072 |
0.18 |
chr5_30152070_30152318 | 5.59 |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
2651 |
0.17 |
chr12_85532591_85532965 | 5.58 |
Gm32296 |
predicted gene, 32296 |
3180 |
0.23 |
chr5_124091870_124092203 | 5.57 |
Abcb9 |
ATP-binding cassette, sub-family B (MDR/TAP), member 9 |
1774 |
0.21 |
chr17_28420185_28420460 | 5.55 |
Fkbp5 |
FK506 binding protein 5 |
1795 |
0.21 |
chr11_111687690_111688154 | 5.54 |
Gm11677 |
predicted gene 11677 |
37702 |
0.2 |
chr8_109865208_109865726 | 5.53 |
Ap1g1 |
adaptor protein complex AP-1, gamma 1 subunit |
2359 |
0.17 |
chr6_38911263_38911582 | 5.50 |
Tbxas1 |
thromboxane A synthase 1, platelet |
7558 |
0.21 |
chr11_100938783_100940230 | 5.50 |
Stat3 |
signal transducer and activator of transcription 3 |
27 |
0.97 |
chr6_97204968_97206158 | 5.47 |
Uba3 |
ubiquitin-like modifier activating enzyme 3 |
2 |
0.97 |
chr13_96698181_96698347 | 5.39 |
Gm48575 |
predicted gene, 48575 |
20141 |
0.14 |
chr5_148740927_148741236 | 5.34 |
2210417A02Rik |
RIKEN cDNA 2210417A02 gene |
759 |
0.59 |
chr18_84884783_84885357 | 5.34 |
Cyb5a |
cytochrome b5 type A (microsomal) |
7469 |
0.17 |
chr7_101616527_101616725 | 5.25 |
Art2b |
ADP-ribosyltransferase 2b |
31026 |
0.12 |
chr16_4586338_4587480 | 5.23 |
Glis2 |
GLIS family zinc finger 2 |
7804 |
0.13 |
chr3_21986580_21986771 | 5.22 |
Gm43674 |
predicted gene 43674 |
11793 |
0.21 |
chr9_55250617_55250793 | 5.21 |
Nrg4 |
neuregulin 4 |
8244 |
0.18 |
chr2_119605771_119605947 | 5.16 |
Oip5os1 |
Opa interacting protein 5, opposite strand 1 |
11556 |
0.1 |
chr15_79391525_79392111 | 5.14 |
Tmem184b |
transmembrane protein 184b |
5038 |
0.12 |
chr9_64049464_64049751 | 5.08 |
Gm25606 |
predicted gene, 25606 |
1111 |
0.4 |
chr13_55189694_55190985 | 5.08 |
Nsd1 |
nuclear receptor-binding SET-domain protein 1 |
19443 |
0.12 |
chr19_53080891_53081464 | 5.08 |
1700054A03Rik |
RIKEN cDNA 1700054A03 gene |
400 |
0.83 |
chr2_132042855_132043675 | 5.06 |
Rassf2 |
Ras association (RalGDS/AF-6) domain family member 2 |
13007 |
0.16 |
chr12_13218119_13218632 | 5.03 |
Ddx1 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 1 |
11004 |
0.19 |
chr9_44397798_44398188 | 5.02 |
Slc37a4 |
solute carrier family 37 (glucose-6-phosphate transporter), member 4 |
183 |
0.8 |
chr1_133685767_133686128 | 5.02 |
Lax1 |
lymphocyte transmembrane adaptor 1 |
4139 |
0.15 |
chr9_67235542_67235843 | 5.01 |
Mir190a |
microRNA 190a |
1034 |
0.55 |
chr7_28053430_28053913 | 4.98 |
Gm44744 |
predicted gene 44744 |
1061 |
0.37 |
chr11_4094091_4094832 | 4.97 |
Mtfp1 |
mitochondrial fission process 1 |
679 |
0.5 |
chr19_6969291_6970359 | 4.91 |
Plcb3 |
phospholipase C, beta 3 |
11 |
0.93 |
chr4_59471420_59471580 | 4.91 |
Ptbp3 |
polypyrimidine tract binding protein 3 |
14272 |
0.18 |
chr11_53794666_53795169 | 4.90 |
Gm12216 |
predicted gene 12216 |
958 |
0.43 |
chr9_67090790_67090949 | 4.88 |
Gm10646 |
predicted gene 10646 |
11431 |
0.16 |
chr16_32487534_32487848 | 4.84 |
Slc51a |
solute carrier family 51, alpha subunit |
12 |
0.96 |
chr16_12697258_12697682 | 4.80 |
Gm38619 |
predicted gene, 38619 |
6898 |
0.28 |
chr7_16046417_16047443 | 4.76 |
Bicra |
BRD4 interacting chromatin remodeling complex associated protein |
991 |
0.44 |
chr11_115833007_115833489 | 4.76 |
Llgl2 |
LLGL2 scribble cell polarity complex component |
677 |
0.52 |
chr11_120744550_120744746 | 4.75 |
Cbr2 |
carbonyl reductase 2 |
12534 |
0.06 |
chr4_132428123_132428546 | 4.73 |
Phactr4 |
phosphatase and actin regulator 4 |
5845 |
0.1 |
chr3_127929993_127930179 | 4.70 |
9830132P13Rik |
RIKEN cDNA 9830132P13 gene |
13914 |
0.14 |
chr15_100599610_100600576 | 4.70 |
Pou6f1 |
POU domain, class 6, transcription factor 1 |
109 |
0.48 |
chr13_109481377_109481735 | 4.70 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
39373 |
0.23 |
chr1_86479174_86479713 | 4.68 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
5784 |
0.15 |
chr5_122137161_122137351 | 4.65 |
Ccdc63 |
coiled-coil domain containing 63 |
806 |
0.53 |
chr19_42891740_42891891 | 4.64 |
Hps1 |
HPS1, biogenesis of lysosomal organelles complex 3 subunit 1 |
111837 |
0.06 |
chr4_123286418_123286738 | 4.63 |
Pabpc4 |
poly(A) binding protein, cytoplasmic 4 |
3483 |
0.12 |
chr1_181257261_181257857 | 4.58 |
Rpl35a-ps2 |
ribosomal protein L35A, pseudogene 2 |
15239 |
0.14 |
chr6_136888060_136888239 | 4.56 |
Mgp |
matrix Gla protein |
12326 |
0.1 |
chr9_108340414_108341194 | 4.52 |
Gpx1 |
glutathione peroxidase 1 |
1528 |
0.17 |
chr2_156295780_156296095 | 4.52 |
Phf20 |
PHD finger protein 20 |
92 |
0.94 |
chr8_122546722_122547355 | 4.52 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
4291 |
0.11 |
chr7_17058026_17058724 | 4.51 |
4833404L02Rik |
RIKEN cDNA 4833404L02 gene |
159 |
0.9 |
chr7_28381734_28382348 | 4.50 |
Zfp36 |
zinc finger protein 36 |
1788 |
0.15 |
chr4_130662932_130663461 | 4.50 |
Pum1 |
pumilio RNA-binding family member 1 |
125 |
0.97 |
chr5_134433226_134433398 | 4.46 |
Gm26340 |
predicted gene, 26340 |
15262 |
0.1 |
chr10_25118684_25119408 | 4.45 |
Gm22566 |
predicted gene, 22566 |
64906 |
0.09 |
chr10_117301874_117302025 | 4.42 |
Lyz1 |
lysozyme 1 |
9081 |
0.14 |
chr11_110010816_110011149 | 4.41 |
Abca8b |
ATP-binding cassette, sub-family A (ABC1), member 8b |
15137 |
0.2 |
chr4_44068879_44069147 | 4.41 |
Gne |
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
1952 |
0.25 |
chr18_35829993_35830906 | 4.38 |
Cxxc5 |
CXXC finger 5 |
135 |
0.85 |
chr17_50331435_50331780 | 4.38 |
Gm49906 |
predicted gene, 49906 |
7645 |
0.21 |
chr4_38334865_38335055 | 4.37 |
Gm12380 |
predicted gene 12380 |
71042 |
0.14 |
chr5_100632845_100633119 | 4.37 |
Coq2 |
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase |
31437 |
0.11 |
chr11_60934906_60935369 | 4.36 |
Map2k3 |
mitogen-activated protein kinase kinase 3 |
3071 |
0.17 |
chr11_86580429_86580773 | 4.33 |
Mir21a |
microRNA 21a |
3557 |
0.18 |
chr8_25043790_25044145 | 4.32 |
Htra4 |
HtrA serine peptidase 4 |
5005 |
0.14 |
chr13_44046616_44046767 | 4.32 |
Gm33489 |
predicted gene, 33489 |
28169 |
0.16 |
chr11_107573910_107574210 | 4.31 |
A830035A12Rik |
RIKEN cDNA A830035A12 gene |
25687 |
0.12 |
chr6_143115038_143115455 | 4.31 |
Gm44312 |
predicted gene, 44312 |
9812 |
0.15 |
chr1_193152702_193153255 | 4.30 |
Irf6 |
interferon regulatory factor 6 |
133 |
0.93 |
chr9_50533549_50533716 | 4.28 |
Gm47077 |
predicted gene, 47077 |
4865 |
0.11 |
chr10_25539470_25539870 | 4.26 |
Gm29571 |
predicted gene 29571 |
3284 |
0.21 |
chr3_19650569_19650855 | 4.25 |
Trim55 |
tripartite motif-containing 55 |
6204 |
0.16 |
chr2_15538711_15539023 | 4.24 |
Gm37595 |
predicted gene, 37595 |
7754 |
0.22 |
chr14_75837044_75838069 | 4.23 |
Gm48931 |
predicted gene, 48931 |
3930 |
0.16 |
chr11_48855844_48857180 | 4.22 |
Gm16170 |
predicted gene 16170 |
3019 |
0.13 |
chr15_77911096_77911448 | 4.21 |
Txn2 |
thioredoxin 2 |
4428 |
0.18 |
chr5_112001700_112002600 | 4.21 |
Gm42488 |
predicted gene 42488 |
57915 |
0.13 |
chr10_58394239_58394459 | 4.20 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
24 |
0.98 |
chr11_84442587_84442829 | 4.20 |
Aatf |
apoptosis antagonizing transcription factor |
6825 |
0.26 |
chr6_73014411_73015031 | 4.20 |
Gm20560 |
predicted gene, 20560 |
2678 |
0.26 |
chr7_46830127_46830360 | 4.19 |
Gm45308 |
predicted gene 45308 |
2221 |
0.15 |
chr19_5840567_5840902 | 4.18 |
Neat1 |
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
4525 |
0.09 |
chr19_43811471_43811764 | 4.18 |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
1095 |
0.45 |
chr3_95666184_95666502 | 4.18 |
Mcl1 |
myeloid cell leukemia sequence 1 |
7486 |
0.1 |
chr14_27352503_27352784 | 4.16 |
Arhgef3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
8746 |
0.21 |
chr7_113239877_113240190 | 4.14 |
Arntl |
aryl hydrocarbon receptor nuclear translocator-like |
279 |
0.92 |
chr5_100566956_100567158 | 4.12 |
Plac8 |
placenta-specific 8 |
3634 |
0.17 |
chr5_148569453_148569748 | 4.12 |
1700013A02Rik |
RIKEN cDNA 1700013A02 gene |
15739 |
0.17 |
chr16_8603622_8604209 | 4.10 |
Abat |
4-aminobutyrate aminotransferase |
8963 |
0.12 |
chr11_101063294_101064479 | 4.10 |
Naglu |
alpha-N-acetylglucosaminidase (Sanfilippo disease IIIB) |
6126 |
0.09 |
chr19_55232114_55232505 | 4.09 |
Gucy2g |
guanylate cyclase 2g |
8927 |
0.17 |
chr7_125478459_125478673 | 4.06 |
Nsmce1 |
NSE1 homolog, SMC5-SMC6 complex component |
7 |
0.98 |
chr11_120353462_120354038 | 4.06 |
0610009L18Rik |
RIKEN cDNA 0610009L18 gene |
5072 |
0.09 |
chr13_110696590_110696981 | 4.05 |
Gm33172 |
predicted gene, 33172 |
12873 |
0.25 |
chr6_9834968_9835442 | 4.05 |
Gm5110 |
predicted gene 5110 |
337649 |
0.01 |
chr7_34290925_34291076 | 4.04 |
4931406P16Rik |
RIKEN cDNA 4931406P16 gene |
5401 |
0.13 |
chr10_41893702_41894299 | 4.04 |
Sesn1 |
sestrin 1 |
4373 |
0.25 |
chr18_5390246_5390643 | 4.03 |
Gm50065 |
predicted gene, 50065 |
19962 |
0.19 |
chr4_139535052_139535706 | 4.03 |
Iffo2 |
intermediate filament family orphan 2 |
3690 |
0.22 |
chr15_88867140_88867804 | 4.02 |
Pim3 |
proviral integration site 3 |
2552 |
0.2 |
chr4_150798850_150799180 | 4.00 |
Gm13049 |
predicted gene 13049 |
26718 |
0.15 |
chr8_90907824_90909226 | 4.00 |
Chd9 |
chromodomain helicase DNA binding protein 9 |
89 |
0.52 |
chr18_74422546_74422719 | 4.00 |
Gm50168 |
predicted gene, 50168 |
1827 |
0.32 |
chr17_70852954_70853810 | 3.99 |
Tgif1 |
TGFB-induced factor homeobox 1 |
164 |
0.72 |
chr1_193172906_193173338 | 3.98 |
A130010J15Rik |
RIKEN cDNA A130010J15 gene |
346 |
0.78 |
chr15_59481091_59481335 | 3.97 |
Nsmce2 |
NSE2/MMS21 homolog, SMC5-SMC6 complex SUMO ligase |
106926 |
0.06 |
chr3_27899135_27899403 | 3.96 |
Tmem212 |
transmembrane protein 212 |
2901 |
0.3 |
chr10_120914717_120915223 | 3.96 |
Gm16166 |
predicted gene 16166 |
13216 |
0.13 |
chr7_128270911_128271083 | 3.96 |
Slc5a2 |
solute carrier family 5 (sodium/glucose cotransporter), member 2 |
423 |
0.67 |
chr7_70358895_70359853 | 3.95 |
Nr2f2 |
nuclear receptor subfamily 2, group F, member 2 |
521 |
0.68 |
chr4_45513877_45514278 | 3.95 |
Gm22518 |
predicted gene, 22518 |
13525 |
0.14 |
chr19_46975611_46975792 | 3.95 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
6133 |
0.17 |
chr9_24896847_24897300 | 3.94 |
Gm48255 |
predicted gene, 48255 |
55900 |
0.09 |
chr3_95318568_95318912 | 3.93 |
Cers2 |
ceramide synthase 2 |
52 |
0.94 |
chr9_110877966_110878153 | 3.93 |
Tmie |
transmembrane inner ear |
1246 |
0.23 |
chr18_61236081_61236409 | 3.93 |
Pde6a |
phosphodiesterase 6A, cGMP-specific, rod, alpha |
15930 |
0.14 |
chr7_35814833_35815224 | 3.93 |
Zfp507 |
zinc finger protein 507 |
12025 |
0.17 |
chr11_116014914_116015211 | 3.92 |
Galk1 |
galactokinase 1 |
2343 |
0.16 |
chr3_96555067_96555630 | 3.92 |
Gm15441 |
predicted gene 15441 |
2467 |
0.11 |
chr19_46849013_46849186 | 3.91 |
Cnnm2 |
cyclin M2 |
16561 |
0.17 |
chr12_111386660_111387150 | 3.91 |
Cdc42bpb |
CDC42 binding protein kinase beta |
9187 |
0.13 |
chr1_166002288_166003185 | 3.90 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr1_185469823_185470016 | 3.90 |
Gm2061 |
predicted gene 2061 |
14351 |
0.12 |
chr11_32297334_32297674 | 3.90 |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
876 |
0.41 |
chr3_146655601_146655765 | 3.89 |
4930503B20Rik |
RIKEN cDNA 4930503B20 gene |
4366 |
0.15 |
chr2_68796050_68796462 | 3.88 |
Gm13612 |
predicted gene 13612 |
34761 |
0.14 |
chr12_80103423_80104027 | 3.88 |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
9269 |
0.12 |
chr17_33781174_33781689 | 3.88 |
Angptl4 |
angiopoietin-like 4 |
112 |
0.91 |
chr14_69523086_69523268 | 3.87 |
Gm27179 |
predicted gene 27179 |
10628 |
0.1 |
chr18_62169607_62169784 | 3.87 |
Adrb2 |
adrenergic receptor, beta 2 |
10264 |
0.19 |
chr7_128289110_128289522 | 3.87 |
BC017158 |
cDNA sequence BC017158 |
611 |
0.44 |
chr14_69304834_69305018 | 3.87 |
Synb |
syncytin b |
10627 |
0.09 |
chr11_102364061_102364256 | 3.84 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
454 |
0.69 |
chrX_75128423_75128651 | 3.84 |
Mpp1 |
membrane protein, palmitoylated |
2307 |
0.17 |
chr9_123457220_123457691 | 3.83 |
Lars2 |
leucyl-tRNA synthetase, mitochondrial |
2665 |
0.26 |
chr2_65275432_65275991 | 3.83 |
Gm13592 |
predicted gene 13592 |
1706 |
0.33 |
chr5_28055448_28055803 | 3.82 |
Gm26608 |
predicted gene, 26608 |
166 |
0.94 |
chr7_103865311_103865713 | 3.80 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
12296 |
0.06 |
chr19_28743359_28743791 | 3.80 |
Rps15a-ps2 |
ribosomal protein S15A, pseudogene 2 |
1024 |
0.51 |
chr16_49800061_49800448 | 3.78 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
279 |
0.89 |
chr6_5297603_5298489 | 3.77 |
Pon2 |
paraoxonase 2 |
284 |
0.91 |
chr1_191641396_191641769 | 3.77 |
Gm37349 |
predicted gene, 37349 |
43935 |
0.11 |
chr11_121543239_121543804 | 3.76 |
Tbcd |
tubulin-specific chaperone d |
680 |
0.7 |
chr11_103007156_103007353 | 3.76 |
Mir6931 |
microRNA 6931 |
7333 |
0.12 |
chr10_59310791_59310954 | 3.75 |
P4ha1 |
procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide |
12424 |
0.2 |
chr18_35848127_35849279 | 3.75 |
Cxxc5 |
CXXC finger 5 |
5984 |
0.11 |
chr4_133701094_133701537 | 3.74 |
Mir7227 |
microRNA 7227 |
15793 |
0.12 |
chr14_120406886_120407067 | 3.74 |
Mbnl2 |
muscleblind like splicing factor 2 |
10489 |
0.22 |
chr11_86581327_86581590 | 3.74 |
Mir21a |
microRNA 21a |
2700 |
0.21 |
chr8_126805357_126806196 | 3.73 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
33457 |
0.16 |
chr17_49423004_49423196 | 3.73 |
Mocs1 |
molybdenum cofactor synthesis 1 |
5262 |
0.22 |
chr14_120847045_120847329 | 3.71 |
Gm9391 |
predicted gene 9391 |
20029 |
0.15 |
chr5_77130277_77130581 | 3.71 |
Gm15831 |
predicted gene 15831 |
8081 |
0.13 |
chr1_185308967_185309247 | 3.71 |
2010103J01Rik |
RIKEN cDNA 2010103J01 gene |
3080 |
0.12 |
chr8_126736428_126737199 | 3.70 |
Gm45805 |
predicted gene 45805 |
21521 |
0.23 |
chr11_52224593_52224747 | 3.69 |
Skp1a |
S-phase kinase-associated protein 1A |
7325 |
0.12 |
chr9_64044981_64045602 | 3.68 |
Gm25606 |
predicted gene, 25606 |
3205 |
0.17 |
chr1_184675628_184676155 | 3.68 |
Gm38358 |
predicted gene, 38358 |
19143 |
0.14 |
chr8_128112942_128113479 | 3.67 |
Mir21c |
microRNA 21c |
165015 |
0.04 |
chr9_64233716_64234023 | 3.66 |
Uchl4 |
ubiquitin carboxyl-terminal esterase L4 |
1332 |
0.25 |
chr12_24889410_24890042 | 3.65 |
Mboat2 |
membrane bound O-acyltransferase domain containing 2 |
58095 |
0.09 |
chr17_87299012_87299237 | 3.65 |
Ttc7 |
tetratricopeptide repeat domain 7 |
6313 |
0.15 |
chr4_119589443_119589736 | 3.64 |
Foxj3 |
forkhead box J3 |
31753 |
0.1 |
chr16_91363506_91363795 | 3.64 |
Ifnar2 |
interferon (alpha and beta) receptor 2 |
9133 |
0.12 |
chr5_114356551_114356848 | 3.63 |
Myo1h |
myosin 1H |
116 |
0.95 |
chr9_63757305_63758776 | 3.63 |
Smad3 |
SMAD family member 3 |
46 |
0.98 |
chr13_35678066_35678217 | 3.63 |
Gm22126 |
predicted gene, 22126 |
16006 |
0.16 |
chr17_48272064_48272554 | 3.63 |
Treml4 |
triggering receptor expressed on myeloid cells-like 4 |
130 |
0.94 |
chr19_57197186_57197779 | 3.62 |
Ablim1 |
actin-binding LIM protein 1 |
14 |
0.98 |
chr11_103132227_103133103 | 3.62 |
Hexim2 |
hexamethylene bis-acetamide inducible 2 |
236 |
0.88 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 14.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
3.3 | 3.3 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
3.0 | 6.1 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
2.7 | 8.2 | GO:0036166 | phenotypic switching(GO:0036166) |
2.6 | 7.9 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
2.5 | 7.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.4 | 7.2 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
2.4 | 2.4 | GO:0048769 | sarcomerogenesis(GO:0048769) |
2.3 | 6.9 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
2.3 | 9.2 | GO:0008228 | opsonization(GO:0008228) |
2.1 | 8.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.9 | 5.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.9 | 5.6 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
1.8 | 9.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.8 | 9.1 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.8 | 9.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.8 | 5.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.8 | 7.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
1.8 | 1.8 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
1.8 | 7.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.8 | 5.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.8 | 1.8 | GO:1990748 | cellular detoxification(GO:1990748) |
1.7 | 5.2 | GO:0032439 | endosome localization(GO:0032439) |
1.7 | 1.7 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
1.7 | 5.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
1.7 | 5.0 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
1.7 | 3.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.7 | 8.3 | GO:0070627 | ferrous iron import(GO:0070627) |
1.7 | 6.6 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
1.6 | 4.9 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
1.6 | 4.9 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
1.6 | 8.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.6 | 8.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.6 | 4.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.6 | 7.9 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.6 | 4.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.6 | 6.3 | GO:0003195 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
1.6 | 6.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.6 | 4.7 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
1.5 | 3.1 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
1.5 | 7.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
1.5 | 3.0 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
1.5 | 4.4 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.4 | 4.3 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.4 | 4.3 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.4 | 4.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
1.4 | 5.6 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.4 | 5.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.4 | 5.4 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.4 | 6.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.4 | 2.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.3 | 4.0 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.3 | 4.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.3 | 8.0 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
1.3 | 4.0 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
1.3 | 2.7 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.3 | 2.6 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.3 | 2.6 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
1.3 | 5.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.3 | 5.2 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
1.3 | 3.9 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.3 | 3.9 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
1.3 | 7.8 | GO:0015871 | choline transport(GO:0015871) |
1.3 | 3.9 | GO:0009838 | abscission(GO:0009838) |
1.3 | 3.8 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
1.3 | 1.3 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
1.3 | 3.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.3 | 5.1 | GO:0070836 | caveola assembly(GO:0070836) |
1.3 | 1.3 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.3 | 2.5 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.3 | 5.1 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.2 | 5.0 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.2 | 3.7 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.2 | 6.2 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
1.2 | 6.2 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) |
1.2 | 1.2 | GO:0010874 | regulation of cholesterol efflux(GO:0010874) |
1.2 | 4.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.2 | 2.4 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
1.2 | 1.2 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
1.2 | 1.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.2 | 3.6 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.2 | 10.9 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
1.2 | 3.6 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
1.2 | 6.0 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.2 | 3.6 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
1.2 | 3.6 | GO:0040031 | snRNA modification(GO:0040031) |
1.2 | 3.6 | GO:1902896 | terminal web assembly(GO:1902896) |
1.2 | 7.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.2 | 4.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.2 | 3.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.2 | 1.2 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
1.2 | 1.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.1 | 3.4 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.1 | 6.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.1 | 3.4 | GO:0006768 | biotin metabolic process(GO:0006768) |
1.1 | 1.1 | GO:0046078 | dUMP metabolic process(GO:0046078) |
1.1 | 4.6 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
1.1 | 1.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.1 | 1.1 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
1.1 | 1.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
1.1 | 3.4 | GO:0045472 | response to ether(GO:0045472) |
1.1 | 3.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.1 | 3.4 | GO:0000087 | mitotic M phase(GO:0000087) |
1.1 | 5.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
1.1 | 4.5 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.1 | 6.7 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
1.1 | 3.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.1 | 3.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.1 | 3.3 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.1 | 7.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.1 | 3.2 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
1.1 | 2.1 | GO:0002432 | granuloma formation(GO:0002432) |
1.1 | 1.1 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.1 | 1.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
1.1 | 2.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.1 | 7.4 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
1.1 | 3.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.0 | 3.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.0 | 3.1 | GO:0050904 | diapedesis(GO:0050904) |
1.0 | 2.1 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
1.0 | 10.3 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
1.0 | 3.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.0 | 3.1 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.0 | 1.0 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.0 | 3.1 | GO:0032817 | regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) |
1.0 | 1.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
1.0 | 3.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
1.0 | 7.1 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
1.0 | 5.1 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
1.0 | 5.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
1.0 | 6.1 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
1.0 | 1.0 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
1.0 | 3.0 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
1.0 | 2.0 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.0 | 6.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
1.0 | 7.0 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
1.0 | 2.0 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
1.0 | 6.0 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
1.0 | 2.0 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
1.0 | 1.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
1.0 | 1.0 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) sinoatrial node cell development(GO:0060931) |
1.0 | 7.8 | GO:0015670 | carbon dioxide transport(GO:0015670) |
1.0 | 5.8 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
1.0 | 3.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.0 | 3.9 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
1.0 | 8.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
1.0 | 4.8 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.0 | 2.9 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.0 | 3.8 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
1.0 | 11.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.0 | 14.3 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.9 | 2.8 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.9 | 4.7 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.9 | 1.9 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.9 | 1.9 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.9 | 6.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.9 | 3.8 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.9 | 3.8 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.9 | 0.9 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.9 | 1.9 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.9 | 2.8 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.9 | 4.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.9 | 5.6 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.9 | 0.9 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.9 | 1.9 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.9 | 2.8 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.9 | 0.9 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.9 | 17.5 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.9 | 1.8 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.9 | 4.6 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.9 | 4.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.9 | 2.7 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.9 | 9.1 | GO:0034204 | lipid translocation(GO:0034204) |
0.9 | 4.5 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.9 | 3.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.9 | 3.6 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.9 | 2.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.9 | 2.7 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.9 | 2.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.9 | 0.9 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.9 | 0.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.9 | 2.7 | GO:0042117 | monocyte activation(GO:0042117) |
0.9 | 3.6 | GO:0032264 | IMP salvage(GO:0032264) |
0.9 | 2.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.9 | 3.6 | GO:0003383 | apical constriction(GO:0003383) |
0.9 | 9.8 | GO:0030575 | nuclear body organization(GO:0030575) |
0.9 | 7.1 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.9 | 2.7 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.9 | 1.8 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.9 | 5.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.9 | 2.6 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.9 | 2.6 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.9 | 5.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.9 | 4.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.9 | 4.4 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.9 | 2.6 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.9 | 2.6 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.9 | 1.7 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.9 | 3.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.9 | 5.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.9 | 1.7 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.9 | 0.9 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.8 | 3.4 | GO:0006116 | NADH oxidation(GO:0006116) |
0.8 | 1.7 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.8 | 2.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.8 | 9.3 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.8 | 5.9 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.8 | 3.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.8 | 1.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.8 | 1.7 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.8 | 4.2 | GO:0060613 | fat pad development(GO:0060613) |
0.8 | 2.5 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.8 | 0.8 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.8 | 3.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.8 | 2.5 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.8 | 1.7 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.8 | 4.1 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.8 | 3.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.8 | 0.8 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.8 | 4.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.8 | 11.5 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.8 | 12.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.8 | 1.6 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.8 | 4.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.8 | 2.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.8 | 1.6 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.8 | 1.6 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.8 | 9.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.8 | 4.9 | GO:1902222 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.8 | 3.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.8 | 15.4 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.8 | 2.4 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.8 | 2.4 | GO:0003166 | His-Purkinje system development(GO:0003164) bundle of His development(GO:0003166) |
0.8 | 1.6 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.8 | 2.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.8 | 0.8 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.8 | 2.4 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.8 | 4.8 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.8 | 0.8 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.8 | 1.6 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.8 | 4.8 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.8 | 2.4 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.8 | 1.6 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.8 | 2.4 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.8 | 0.8 | GO:0060430 | lung saccule development(GO:0060430) |
0.8 | 0.8 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.8 | 5.6 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.8 | 5.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.8 | 0.8 | GO:1903727 | positive regulation of phospholipid metabolic process(GO:1903727) |
0.8 | 7.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.8 | 5.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.8 | 5.5 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.8 | 0.8 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.8 | 2.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.8 | 0.8 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.8 | 1.5 | GO:0070295 | renal water absorption(GO:0070295) |
0.8 | 2.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.8 | 3.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.8 | 1.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.8 | 1.5 | GO:0003097 | renal water transport(GO:0003097) |
0.8 | 1.5 | GO:0010878 | cholesterol storage(GO:0010878) |
0.8 | 3.1 | GO:0035733 | hepatic stellate cell activation(GO:0035733) |
0.8 | 3.0 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.8 | 0.8 | GO:0033483 | gas homeostasis(GO:0033483) |
0.8 | 0.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.8 | 3.0 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.8 | 0.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.8 | 3.0 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.7 | 5.2 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.7 | 2.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.7 | 7.4 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.7 | 2.2 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.7 | 2.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.7 | 3.7 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.7 | 0.7 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.7 | 3.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.7 | 2.9 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.7 | 0.7 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.7 | 0.7 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.7 | 2.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.7 | 2.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.7 | 5.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.7 | 2.9 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.7 | 0.7 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
0.7 | 0.7 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.7 | 6.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.7 | 3.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.7 | 1.4 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.7 | 11.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.7 | 2.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.7 | 4.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.7 | 2.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.7 | 4.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.7 | 8.6 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.7 | 1.4 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.7 | 2.9 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.7 | 6.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.7 | 0.7 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.7 | 8.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.7 | 2.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.7 | 2.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.7 | 2.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.7 | 1.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.7 | 7.7 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.7 | 1.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.7 | 0.7 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.7 | 2.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.7 | 2.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.7 | 1.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.7 | 0.7 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.7 | 1.4 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.7 | 1.4 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.7 | 1.4 | GO:0003032 | detection of oxygen(GO:0003032) |
0.7 | 2.1 | GO:0009414 | response to water deprivation(GO:0009414) |
0.7 | 2.7 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
0.7 | 1.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.7 | 2.1 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.7 | 2.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.7 | 2.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.7 | 0.7 | GO:1903319 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.7 | 1.4 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.7 | 6.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.7 | 2.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.7 | 1.4 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.7 | 8.8 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.7 | 4.7 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.7 | 4.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.7 | 10.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.7 | 2.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.7 | 4.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.7 | 0.7 | GO:0044532 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
0.7 | 1.3 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.7 | 2.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.7 | 6.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.7 | 0.7 | GO:0009415 | response to water(GO:0009415) response to hydrostatic pressure(GO:0051599) |
0.7 | 2.6 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.7 | 1.3 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.7 | 2.6 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.7 | 2.6 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.7 | 8.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.7 | 3.3 | GO:0018904 | ether metabolic process(GO:0018904) |
0.7 | 1.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.7 | 2.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.7 | 1.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.7 | 1.3 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.7 | 6.5 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.7 | 0.7 | GO:0061440 | renal system vasculature development(GO:0061437) kidney vasculature development(GO:0061440) |
0.7 | 12.4 | GO:0048821 | erythrocyte development(GO:0048821) |
0.7 | 3.3 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.6 | 0.6 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.6 | 1.9 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.6 | 0.6 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.6 | 1.3 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.6 | 1.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.6 | 3.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.6 | 2.6 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.6 | 1.9 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.6 | 3.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.6 | 2.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.6 | 1.3 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.6 | 7.0 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.6 | 3.8 | GO:0048539 | bone marrow development(GO:0048539) |
0.6 | 1.3 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.6 | 1.9 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.6 | 1.3 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.6 | 1.3 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.6 | 3.8 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.6 | 0.6 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.6 | 0.6 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.6 | 5.0 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.6 | 1.9 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.6 | 1.9 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.6 | 1.3 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.6 | 2.5 | GO:0070459 | prolactin secretion(GO:0070459) |
0.6 | 1.3 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.6 | 2.5 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.6 | 2.5 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.6 | 3.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.6 | 1.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.6 | 0.6 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.6 | 1.9 | GO:0042546 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.6 | 1.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.6 | 0.6 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.6 | 2.5 | GO:0051775 | response to redox state(GO:0051775) |
0.6 | 1.2 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.6 | 3.1 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.6 | 1.2 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.6 | 5.5 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.6 | 2.4 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.6 | 3.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.6 | 6.0 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.6 | 3.6 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.6 | 2.4 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.6 | 2.4 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.6 | 1.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.6 | 8.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.6 | 1.2 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.6 | 3.6 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.6 | 2.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.6 | 0.6 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.6 | 0.6 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.6 | 1.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.6 | 1.8 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.6 | 1.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.6 | 0.6 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
0.6 | 3.6 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.6 | 3.6 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.6 | 1.8 | GO:0018343 | protein farnesylation(GO:0018343) |
0.6 | 1.2 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.6 | 1.2 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.6 | 0.6 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.6 | 0.6 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.6 | 1.2 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.6 | 1.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.6 | 2.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.6 | 1.2 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.6 | 3.5 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.6 | 1.2 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.6 | 8.7 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.6 | 0.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.6 | 1.2 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.6 | 1.7 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.6 | 1.2 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.6 | 2.3 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.6 | 0.6 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.6 | 1.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.6 | 1.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.6 | 3.4 | GO:1904754 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.6 | 0.6 | GO:0080009 | mRNA methylation(GO:0080009) |
0.6 | 2.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.6 | 0.6 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.6 | 2.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.6 | 1.1 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.6 | 0.6 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.6 | 2.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.6 | 2.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.6 | 2.8 | GO:0048069 | eye pigmentation(GO:0048069) |
0.6 | 0.6 | GO:0009080 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
0.6 | 1.7 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.6 | 3.9 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.6 | 4.5 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.6 | 1.7 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.6 | 1.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.6 | 5.6 | GO:0014850 | response to muscle activity(GO:0014850) |
0.6 | 2.8 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.6 | 1.7 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.6 | 0.6 | GO:0061724 | lipophagy(GO:0061724) |
0.6 | 1.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.6 | 1.7 | GO:0060056 | mammary gland involution(GO:0060056) |
0.6 | 3.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 2.2 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.5 | 2.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.5 | 4.9 | GO:0007097 | nuclear migration(GO:0007097) |
0.5 | 4.9 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.5 | 1.1 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.5 | 15.2 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.5 | 0.5 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.5 | 1.1 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.5 | 1.1 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.5 | 1.1 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.5 | 2.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.5 | 3.8 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.5 | 1.6 | GO:0071404 | response to low-density lipoprotein particle(GO:0055098) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.5 | 3.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.5 | 1.6 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.5 | 1.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.5 | 1.6 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.5 | 1.6 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.5 | 1.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.5 | 1.6 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.5 | 4.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.5 | 1.1 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.5 | 1.1 | GO:0009139 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.5 | 0.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.5 | 3.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.5 | 1.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.5 | 6.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.5 | 2.6 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.5 | 0.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.5 | 3.7 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.5 | 1.6 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.5 | 1.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.5 | 2.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.5 | 1.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.5 | 2.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.5 | 2.1 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.5 | 1.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.5 | 2.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.5 | 2.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.5 | 2.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.5 | 0.5 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.5 | 5.7 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.5 | 0.5 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.5 | 2.0 | GO:0033572 | transferrin transport(GO:0033572) |
0.5 | 1.5 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.5 | 0.5 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.5 | 9.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.5 | 1.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.5 | 0.5 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.5 | 1.5 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.5 | 1.5 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.5 | 2.0 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.5 | 0.5 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.5 | 4.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.5 | 9.0 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.5 | 1.0 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.5 | 2.0 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.5 | 1.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.5 | 8.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.5 | 0.5 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.5 | 1.5 | GO:0090148 | membrane fission(GO:0090148) |
0.5 | 1.0 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.5 | 1.0 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.5 | 0.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.5 | 1.5 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.5 | 2.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.5 | 1.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 2.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.5 | 1.0 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.5 | 2.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.5 | 2.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.5 | 2.4 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.5 | 2.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 1.0 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.5 | 5.8 | GO:0002347 | response to tumor cell(GO:0002347) |
0.5 | 1.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.5 | 0.5 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.5 | 1.9 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.5 | 4.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.5 | 1.4 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.5 | 2.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.5 | 1.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.5 | 2.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.5 | 1.4 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.5 | 0.5 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.5 | 0.5 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.5 | 1.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.5 | 2.4 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.5 | 1.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.5 | 1.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.5 | 1.0 | GO:0006868 | glutamine transport(GO:0006868) |
0.5 | 1.0 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.5 | 2.8 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.5 | 4.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.5 | 0.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.5 | 3.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.5 | 4.7 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.5 | 1.4 | GO:0060631 | regulation of meiosis I(GO:0060631) positive regulation of meiosis I(GO:0060903) |
0.5 | 1.9 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.5 | 0.9 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.5 | 3.7 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.5 | 2.8 | GO:0006477 | protein sulfation(GO:0006477) |
0.5 | 0.5 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.5 | 3.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.5 | 6.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.5 | 6.9 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.5 | 0.9 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.5 | 0.9 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.5 | 1.8 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.5 | 1.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.5 | 0.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.5 | 1.8 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.5 | 0.5 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.5 | 1.4 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.5 | 0.5 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.5 | 1.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.5 | 1.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.5 | 4.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.5 | 2.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.5 | 0.5 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.5 | 0.5 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.4 | 1.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.4 | 0.4 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.4 | 4.9 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.4 | 1.8 | GO:0015705 | iodide transport(GO:0015705) |
0.4 | 1.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.4 | 4.9 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.4 | 0.9 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.4 | 0.4 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.4 | 0.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.4 | 11.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.4 | 0.4 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.4 | 0.4 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.4 | 4.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.4 | 0.4 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.4 | 0.4 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.4 | 0.9 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.4 | 2.2 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.4 | 4.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.4 | 0.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 0.4 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.4 | 0.9 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.4 | 2.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.4 | 0.4 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.4 | 3.9 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.4 | 1.3 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.4 | 0.4 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.4 | 0.4 | GO:1903044 | protein transport into membrane raft(GO:0032596) protein localization to membrane raft(GO:1903044) |
0.4 | 8.7 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.4 | 2.6 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.4 | 1.3 | GO:0018101 | protein citrullination(GO:0018101) |
0.4 | 0.4 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.4 | 2.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 0.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.4 | 1.7 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.4 | 1.3 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.4 | 0.9 | GO:1901838 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.4 | 1.7 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.4 | 2.1 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.4 | 0.4 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.4 | 3.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 0.4 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.4 | 1.3 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.4 | 0.8 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.4 | 3.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.4 | 0.8 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.4 | 0.8 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.4 | 4.2 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.4 | 0.4 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.4 | 2.1 | GO:0006903 | vesicle targeting(GO:0006903) |
0.4 | 0.8 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.4 | 0.8 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.4 | 0.4 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.4 | 1.7 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.4 | 1.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.4 | 0.8 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.4 | 1.7 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.4 | 2.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.4 | 0.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.4 | 0.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.4 | 5.8 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.4 | 0.8 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.4 | 0.8 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.4 | 0.4 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.4 | 2.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 1.6 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.4 | 3.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.4 | 1.2 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.4 | 1.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.4 | 2.5 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.4 | 0.8 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.4 | 0.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 4.5 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.4 | 2.9 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.4 | 0.8 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.4 | 0.8 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.4 | 1.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.4 | 0.8 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.4 | 2.0 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.4 | 2.0 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.4 | 8.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.4 | 0.8 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.4 | 1.2 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.4 | 1.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.4 | 2.0 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.4 | 2.8 | GO:0070269 | pyroptosis(GO:0070269) |
0.4 | 5.9 | GO:0017144 | drug metabolic process(GO:0017144) |
0.4 | 2.4 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.4 | 1.2 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.4 | 1.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.4 | 2.7 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.4 | 3.9 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.4 | 6.7 | GO:0010761 | fibroblast migration(GO:0010761) |
0.4 | 1.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 1.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.4 | 1.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.4 | 3.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.4 | 1.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.4 | 1.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.4 | 0.4 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.4 | 0.8 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.4 | 2.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.4 | 0.8 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.4 | 2.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.4 | 6.2 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.4 | 1.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.4 | 4.6 | GO:0043486 | histone exchange(GO:0043486) |
0.4 | 0.8 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.4 | 1.9 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.4 | 1.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.4 | 0.4 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.4 | 2.3 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.4 | 0.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.4 | 0.8 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.4 | 1.9 | GO:0097421 | liver regeneration(GO:0097421) |
0.4 | 1.5 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.4 | 0.4 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.4 | 2.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.4 | 1.5 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 1.1 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.4 | 3.8 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.4 | 1.1 | GO:0009597 | detection of virus(GO:0009597) |
0.4 | 1.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.4 | 0.4 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.4 | 1.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.4 | 1.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.4 | 2.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.4 | 0.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.4 | 1.5 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.4 | 0.4 | GO:1901858 | regulation of mitochondrial DNA replication(GO:0090296) regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.4 | 2.6 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.4 | 0.8 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.4 | 1.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.4 | 3.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.4 | 4.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.4 | 0.4 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.4 | 1.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.4 | 0.7 | GO:0002215 | defense response to nematode(GO:0002215) |
0.4 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 0.7 | GO:0036507 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.4 | 0.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.4 | 0.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.4 | 7.0 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.4 | 2.6 | GO:0014823 | response to activity(GO:0014823) |
0.4 | 1.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.4 | 0.7 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.4 | 0.4 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.4 | 1.5 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.4 | 1.1 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.4 | 1.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.4 | 7.0 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.4 | 0.4 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.4 | 1.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.4 | 1.8 | GO:0046697 | decidualization(GO:0046697) |
0.4 | 1.5 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.4 | 1.1 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.4 | 0.4 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.4 | 8.0 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.4 | 1.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.4 | 0.7 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.4 | 2.5 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.4 | 0.7 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.4 | 1.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.4 | 1.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.4 | 0.4 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.4 | 0.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.4 | 1.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.4 | 2.5 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.4 | 2.9 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.4 | 2.8 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.4 | 0.7 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.4 | 0.4 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.4 | 4.3 | GO:0006828 | manganese ion transport(GO:0006828) |
0.4 | 1.1 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.4 | 0.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.4 | 1.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.4 | 0.7 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.4 | 1.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.4 | 0.4 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.4 | 1.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.4 | 2.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.4 | 1.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 1.1 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) positive regulation by host of viral genome replication(GO:0044829) |
0.4 | 2.8 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.4 | 1.4 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.3 | 3.8 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 2.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.3 | 0.3 | GO:0043471 | regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
0.3 | 0.7 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.3 | 0.7 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 0.3 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.3 | 2.1 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 1.0 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.3 | 2.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 0.7 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.3 | 0.3 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.3 | 0.3 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.3 | 2.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.3 | 0.7 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 1.7 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.3 | 1.0 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 0.3 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.3 | 0.7 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.3 | 0.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.3 | 0.7 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 4.8 | GO:0019915 | lipid storage(GO:0019915) |
0.3 | 1.4 | GO:0015809 | arginine transport(GO:0015809) |
0.3 | 2.7 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.3 | 1.4 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.3 | 1.7 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 0.3 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.3 | 1.0 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.3 | 0.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 1.0 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.3 | 2.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 1.7 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.3 | 0.7 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.3 | 1.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 1.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.3 | 0.7 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.3 | 0.7 | GO:0046836 | glycolipid transport(GO:0046836) |
0.3 | 1.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 1.3 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.3 | 0.7 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.3 | 0.7 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.3 | 3.3 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.3 | 0.7 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.3 | 1.0 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.3 | 0.3 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.3 | 3.6 | GO:1901741 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
0.3 | 0.3 | GO:0035912 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.3 | 2.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 1.0 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.3 | 1.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 0.3 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.3 | 0.3 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.3 | 1.0 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 2.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.3 | 1.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 1.0 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 5.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.3 | 1.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 1.0 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.3 | 1.0 | GO:0006833 | water transport(GO:0006833) |
0.3 | 0.3 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.3 | 2.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.3 | 0.3 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.3 | 0.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.3 | 0.6 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.3 | 0.3 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.3 | 1.9 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.3 | 0.6 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.3 | 0.3 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.3 | 1.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.3 | 1.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.3 | 1.6 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.3 | 1.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 0.3 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.3 | 0.3 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.3 | 1.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.3 | 0.6 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.3 | 0.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.3 | 0.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.3 | 0.3 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.3 | 0.6 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.3 | 1.9 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.3 | 1.9 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 8.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.3 | 2.2 | GO:0009650 | UV protection(GO:0009650) |
0.3 | 1.3 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 4.1 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
0.3 | 4.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 1.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 1.2 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.3 | 0.9 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.3 | 0.3 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.3 | 0.6 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.3 | 0.6 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.3 | 2.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 2.2 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.3 | 3.1 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.3 | 0.6 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.3 | 1.5 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.3 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.3 | 0.6 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.3 | 1.5 | GO:0006415 | translational termination(GO:0006415) |
0.3 | 4.3 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 1.5 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.3 | 0.6 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.3 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.3 | 3.0 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.3 | 0.9 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 1.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 4.5 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.3 | 0.9 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.3 | 0.9 | GO:0051917 | regulation of fibrinolysis(GO:0051917) |
0.3 | 0.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.3 | 2.4 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.3 | 0.9 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.3 | 0.9 | GO:0031639 | plasminogen activation(GO:0031639) |
0.3 | 2.7 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.3 | 11.4 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.3 | 0.9 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 0.3 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.3 | 1.2 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.3 | 8.4 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.3 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.3 | 2.4 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.3 | 0.6 | GO:0010226 | response to lithium ion(GO:0010226) |
0.3 | 2.1 | GO:1902624 | positive regulation of neutrophil migration(GO:1902624) |
0.3 | 2.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 1.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.3 | 6.5 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.3 | 1.8 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.3 | 1.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.3 | 0.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.3 | 1.2 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.3 | 0.3 | GO:0070254 | mucus secretion(GO:0070254) regulation of mucus secretion(GO:0070255) |
0.3 | 2.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 0.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 2.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.3 | 0.9 | GO:0035931 | renin-angiotensin regulation of aldosterone production(GO:0002018) mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.3 | 2.0 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 0.6 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.3 | 2.9 | GO:0048535 | lymph node development(GO:0048535) |
0.3 | 0.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.3 | 0.9 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.3 | 2.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.3 | 0.9 | GO:0015744 | succinate transport(GO:0015744) |
0.3 | 0.6 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.3 | 1.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.3 | 0.9 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 0.6 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.3 | 0.3 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.3 | 0.9 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.3 | 1.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.3 | 1.7 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.3 | 9.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 0.6 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.3 | 1.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 1.7 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.3 | 1.7 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.3 | 1.1 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.3 | 3.1 | GO:0043489 | RNA stabilization(GO:0043489) |
0.3 | 0.8 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 0.8 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 0.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 1.7 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 0.3 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.3 | 0.8 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.3 | 1.1 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.3 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.3 | 0.8 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.3 | 2.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.3 | 0.6 | GO:0031100 | organ regeneration(GO:0031100) |
0.3 | 0.3 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.3 | 1.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 2.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.3 | 0.8 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.3 | 2.2 | GO:0070166 | enamel mineralization(GO:0070166) |
0.3 | 6.8 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.3 | 1.6 | GO:0042255 | ribosome assembly(GO:0042255) |
0.3 | 0.3 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
0.3 | 3.5 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.3 | 1.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 0.5 | GO:0033363 | secretory granule organization(GO:0033363) |
0.3 | 0.8 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.3 | 1.1 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.3 | 1.9 | GO:0070266 | necroptotic process(GO:0070266) |
0.3 | 4.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.3 | 0.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.3 | 0.5 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.3 | 0.8 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 1.1 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.3 | 0.3 | GO:0070384 | Harderian gland development(GO:0070384) |
0.3 | 1.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.3 | 0.3 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 0.3 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.3 | 3.5 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.3 | 0.3 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.3 | 3.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.3 | 2.9 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.3 | 0.5 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.3 | 0.3 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.3 | 0.5 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.3 | 1.1 | GO:0002591 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.3 | 0.3 | GO:0002086 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.3 | 0.5 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 1.1 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.3 | 6.5 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.3 | 0.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.3 | 0.5 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.3 | 1.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 2.3 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.3 | 0.8 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.3 | 1.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 0.3 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.3 | 0.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 1.0 | GO:1901070 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) guanosine-containing compound biosynthetic process(GO:1901070) |
0.3 | 0.8 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.3 | 0.3 | GO:0015747 | urate transport(GO:0015747) |
0.3 | 1.0 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.3 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 0.5 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 0.3 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.3 | 1.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.3 | 3.6 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.3 | 1.0 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.3 | 2.5 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.3 | 2.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 5.8 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.3 | 4.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.3 | 0.3 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.3 | 2.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.3 | 3.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.3 | 2.3 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.3 | 0.3 | GO:0070339 | response to bacterial lipoprotein(GO:0032493) response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.3 | 0.3 | GO:0018214 | protein carboxylation(GO:0018214) |
0.3 | 0.3 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 1.5 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.2 | 0.5 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.2 | 0.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 2.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 1.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.2 | 0.5 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 0.5 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.2 | 0.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.2 | 1.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.2 | 1.0 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 0.5 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 0.5 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.2 | 2.5 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.2 | 0.7 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.7 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.2 | 0.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 0.5 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.2 | 0.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 4.1 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.2 | 0.2 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
0.2 | 1.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.2 | 0.2 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.2 | 2.9 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.2 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 0.7 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.2 | 1.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 0.5 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.2 | 3.6 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 4.8 | GO:0009206 | purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
0.2 | 1.9 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 1.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 0.5 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 9.5 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 0.9 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.2 | 0.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 1.4 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.2 | 0.7 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.2 | 3.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 1.9 | GO:0050892 | intestinal absorption(GO:0050892) |
0.2 | 0.2 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 0.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.2 | 3.0 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.2 | 1.4 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.2 | 3.5 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.2 | 0.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.2 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 0.2 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.2 | 1.9 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 0.2 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.2 | 2.5 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.2 | 0.5 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 0.9 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.2 | 0.5 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 0.2 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.2 | 0.7 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 0.5 | GO:0036492 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.2 | 0.9 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.2 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 0.5 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 0.7 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.2 | 0.9 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 0.5 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.2 | 0.9 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 0.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 0.7 | GO:0034982 | protein processing involved in protein targeting to mitochondrion(GO:0006627) mitochondrial protein processing(GO:0034982) |
0.2 | 0.7 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.7 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.2 | 1.5 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.2 | 0.2 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.2 | 1.8 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.2 | 1.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.2 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.2 | 0.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.9 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 0.4 | GO:0007567 | parturition(GO:0007567) |
0.2 | 1.3 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.2 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 0.2 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.2 | 0.6 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 0.4 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.2 | 2.2 | GO:0046364 | monosaccharide biosynthetic process(GO:0046364) |
0.2 | 0.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 1.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 0.4 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.2 | 0.4 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.2 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.2 | 2.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 1.5 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 0.2 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.2 | 2.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.2 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.2 | 0.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 1.9 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 5.1 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 0.4 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.2 | 0.4 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 0.2 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 1.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 2.3 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.2 | 0.4 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 1.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.2 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
0.2 | 0.4 | GO:0042730 | fibrinolysis(GO:0042730) |
0.2 | 2.0 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.2 | 5.9 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.2 | 2.0 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 1.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 0.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 1.8 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.2 | 1.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.4 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.2 | 3.4 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.2 | 0.4 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.2 | 0.8 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.2 | 1.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 1.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 7.0 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.2 | 2.9 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 1.2 | GO:0010447 | response to acidic pH(GO:0010447) |
0.2 | 0.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 0.2 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.2 | 0.2 | GO:0060066 | ectoderm formation(GO:0001705) oviduct development(GO:0060066) |
0.2 | 0.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 2.9 | GO:0043297 | apical junction assembly(GO:0043297) |
0.2 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.2 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 0.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 1.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 0.4 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.2 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.4 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.2 | 3.0 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.2 | 3.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 0.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.2 | 2.8 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.2 | 6.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 0.6 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 4.8 | GO:0031929 | TOR signaling(GO:0031929) |
0.2 | 0.2 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.2 | 0.2 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.2 | 0.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.2 | GO:0045404 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.2 | 0.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.5 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.2 | 0.2 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.2 | 2.5 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.2 | 3.4 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.2 | 3.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 0.7 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.7 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.2 | 0.9 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 0.4 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.2 | 0.2 | GO:0010742 | macrophage derived foam cell differentiation(GO:0010742) |
0.2 | 0.4 | GO:0033574 | response to testosterone(GO:0033574) |
0.2 | 0.9 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.2 | 1.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.2 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.2 | 0.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 1.9 | GO:0001706 | endoderm formation(GO:0001706) |
0.2 | 0.2 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.2 | 0.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 0.2 | GO:1903671 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
0.2 | 0.2 | GO:0032608 | interferon-beta production(GO:0032608) |
0.2 | 1.0 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 8.2 | GO:0051236 | establishment of RNA localization(GO:0051236) |
0.2 | 0.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.2 | 0.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 2.8 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 1.0 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.2 | 0.7 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 2.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 0.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.2 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.2 | 0.8 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 1.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.2 | 0.2 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.2 | 0.8 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 0.5 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.2 | 1.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 1.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.8 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.2 | 0.3 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 1.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 0.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.2 | 0.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 2.6 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.2 | 1.8 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.2 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 1.3 | GO:0051168 | nuclear export(GO:0051168) |
0.2 | 0.2 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.2 | 0.2 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.2 | 0.5 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 0.3 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.2 | 0.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 1.0 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.2 | 1.8 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.2 | 2.6 | GO:0015914 | phospholipid transport(GO:0015914) |
0.2 | 0.3 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.2 | 2.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 0.3 | GO:0044838 | cell quiescence(GO:0044838) |
0.2 | 0.3 | GO:0072224 | metanephric glomerulus development(GO:0072224) |
0.2 | 0.5 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 0.2 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.2 | 0.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.3 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.2 | 0.2 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.2 | 0.2 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 0.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.5 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.2 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.2 | 0.8 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 1.1 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.2 | 0.6 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.2 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 0.6 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 0.5 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.2 | 0.8 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.2 | 0.2 | GO:0051132 | NK T cell activation(GO:0051132) |
0.2 | 2.1 | GO:0016925 | protein sumoylation(GO:0016925) |
0.2 | 1.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 1.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 1.0 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 0.3 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.1 | 0.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 4.0 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.1 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 0.3 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.1 | 1.0 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.1 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.1 | 0.6 | GO:1902116 | negative regulation of organelle assembly(GO:1902116) |
0.1 | 1.3 | GO:1905037 | autophagosome organization(GO:1905037) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.6 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.1 | 0.6 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 1.4 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.1 | 1.0 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.1 | 0.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.4 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.8 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 1.0 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.1 | 0.6 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.1 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.1 | 0.3 | GO:0002337 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
0.1 | 0.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.3 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.1 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.1 | 0.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 3.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.9 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.8 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 0.1 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 2.3 | GO:0060323 | head morphogenesis(GO:0060323) |
0.1 | 0.9 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.3 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.1 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.1 | 4.1 | GO:0043038 | amino acid activation(GO:0043038) |
0.1 | 1.2 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.8 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.7 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.1 | 0.4 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.3 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.1 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) regulation of MDA-5 signaling pathway(GO:0039533) positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 2.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.3 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.7 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.1 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.1 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 3.9 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 1.8 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.1 | 0.5 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 0.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.9 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.9 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.1 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.1 | 0.4 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.1 | 3.5 | GO:0015758 | glucose transport(GO:0015758) |
0.1 | 2.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.4 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.4 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.7 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.2 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 0.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 1.1 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.1 | 0.5 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.6 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 1.5 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.5 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.1 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 1.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 1.9 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.4 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 0.4 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.9 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.2 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 0.3 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.2 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.1 | 1.7 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 5.6 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.2 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.2 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.1 | 0.2 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.1 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 0.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.3 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.3 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.1 | 0.2 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.1 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.1 | 0.2 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 2.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.3 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.8 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.4 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.9 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.1 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.3 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.5 | GO:0071467 | cellular response to pH(GO:0071467) |
0.1 | 0.4 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.3 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.1 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.1 | 0.7 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.1 | GO:0071827 | plasma lipoprotein particle organization(GO:0071827) |
0.1 | 0.6 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 1.9 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 5.7 | GO:0007596 | blood coagulation(GO:0007596) coagulation(GO:0050817) |
0.1 | 0.4 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
0.1 | 2.9 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.1 | GO:0090504 | epiboly(GO:0090504) |
0.1 | 0.4 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 1.4 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.8 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.3 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.1 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.1 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.1 | 0.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.3 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) |
0.1 | 0.2 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.7 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.1 | GO:0007599 | hemostasis(GO:0007599) |
0.1 | 2.5 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.7 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.5 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.1 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.1 | 0.2 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.3 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 0.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.1 | 0.5 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.1 | 0.1 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.1 | 0.3 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.4 | GO:1901184 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) regulation of ERBB signaling pathway(GO:1901184) |
0.1 | 1.0 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 1.8 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.3 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.1 | GO:0006007 | glucose catabolic process(GO:0006007) fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.1 | 0.3 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 1.0 | GO:0006073 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 0.2 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 1.8 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 1.2 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.1 | 0.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 3.3 | GO:0033559 | unsaturated fatty acid metabolic process(GO:0033559) |
0.1 | 0.7 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.1 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.1 | 0.1 | GO:0061009 | common bile duct development(GO:0061009) |
0.1 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.9 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 0.4 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.6 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 1.3 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.2 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
0.1 | 0.1 | GO:2000662 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.1 | 0.4 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.1 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.5 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 0.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.6 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 3.2 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.1 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.1 | 0.3 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.1 | 0.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.1 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.1 | 0.4 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.1 | 0.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.2 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.3 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.1 | 0.1 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.1 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 2.0 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.2 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 1.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.2 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.1 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.8 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.1 | 0.2 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 0.2 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.3 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.2 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.1 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.1 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 1.1 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.5 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.1 | 0.2 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 2.0 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 0.2 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.0 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.0 | 0.1 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.4 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 3.9 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.1 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 2.3 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.2 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.0 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.0 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.3 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.0 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.0 | 0.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.0 | 0.2 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.0 | 0.0 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.0 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.5 | GO:0043627 | response to estrogen(GO:0043627) |
0.0 | 0.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.3 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.0 | 0.0 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.4 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.0 | 0.2 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 0.1 | GO:0071384 | cellular response to corticosteroid stimulus(GO:0071384) |
0.0 | 0.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.4 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.0 | 0.0 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.0 | 0.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.0 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.0 | 0.8 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.0 | 1.3 | GO:0016573 | histone acetylation(GO:0016573) |
0.0 | 0.3 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.0 | 0.1 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 0.1 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.0 | 0.0 | GO:0045939 | negative regulation of steroid biosynthetic process(GO:0010894) negative regulation of steroid metabolic process(GO:0045939) |
0.0 | 0.3 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.0 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.0 | 0.4 | GO:0006476 | protein deacetylation(GO:0006476) |
0.0 | 0.0 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.0 | 0.1 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.0 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.3 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.0 | 0.1 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.2 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.0 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.6 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.0 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.0 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.0 | 0.0 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.0 | 0.0 | GO:0002922 | positive regulation of humoral immune response(GO:0002922) |
0.0 | 0.0 | GO:2001055 | endothelial cell fate specification(GO:0060847) positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.0 | 0.0 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.0 | 0.1 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.0 | 0.0 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.2 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.2 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.0 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.0 | 0.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.5 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.0 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.0 | 1.1 | GO:0090174 | organelle membrane fusion(GO:0090174) |
0.0 | 0.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.0 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.0 | 0.0 | GO:0060180 | regulation of female receptivity(GO:0045924) female mating behavior(GO:0060180) |
0.0 | 0.8 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.0 | GO:0070542 | response to fatty acid(GO:0070542) |
0.0 | 3.0 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.9 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.1 | GO:0032400 | melanosome localization(GO:0032400) |
0.0 | 0.0 | GO:0060193 | positive regulation of lipase activity(GO:0060193) |
0.0 | 0.3 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 5.9 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.9 | 9.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.9 | 5.6 | GO:0097413 | Lewy body(GO:0097413) |
1.8 | 5.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.7 | 1.7 | GO:0005652 | nuclear lamina(GO:0005652) |
1.7 | 5.0 | GO:0097443 | sorting endosome(GO:0097443) |
1.6 | 8.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.6 | 4.7 | GO:0016459 | myosin complex(GO:0016459) |
1.6 | 6.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.5 | 4.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.4 | 4.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.4 | 7.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.4 | 4.2 | GO:0097513 | myosin II filament(GO:0097513) |
1.4 | 2.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.4 | 2.8 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
1.4 | 6.9 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.3 | 4.0 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.3 | 5.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.3 | 3.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.2 | 9.7 | GO:0045179 | apical cortex(GO:0045179) |
1.2 | 4.8 | GO:0033269 | internode region of axon(GO:0033269) |
1.2 | 1.2 | GO:1990423 | RZZ complex(GO:1990423) |
1.2 | 4.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.1 | 2.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.1 | 7.4 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
1.0 | 4.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.0 | 5.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.0 | 5.8 | GO:0097470 | ribbon synapse(GO:0097470) |
1.0 | 5.8 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.0 | 6.8 | GO:0042382 | paraspeckles(GO:0042382) |
1.0 | 4.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.9 | 7.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.9 | 9.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.9 | 2.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.9 | 0.9 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.9 | 2.8 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.9 | 5.5 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.9 | 2.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.9 | 2.6 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.9 | 4.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.9 | 10.3 | GO:0043034 | costamere(GO:0043034) |
0.9 | 9.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.8 | 0.8 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.8 | 2.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.8 | 3.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.8 | 3.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.8 | 2.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.8 | 2.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.8 | 45.2 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.8 | 4.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.8 | 2.4 | GO:0005745 | m-AAA complex(GO:0005745) |
0.8 | 4.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.8 | 1.6 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.8 | 4.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.8 | 7.8 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.8 | 2.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.8 | 7.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.8 | 3.9 | GO:0008091 | spectrin(GO:0008091) |
0.8 | 4.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.8 | 6.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.8 | 4.6 | GO:0005818 | aster(GO:0005818) |
0.8 | 0.8 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.8 | 6.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.7 | 3.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.7 | 0.7 | GO:0030666 | clathrin coat of endocytic vesicle(GO:0030128) endocytic vesicle membrane(GO:0030666) clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.7 | 2.9 | GO:0044194 | cytolytic granule(GO:0044194) |
0.7 | 5.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.7 | 3.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.7 | 1.4 | GO:0032432 | actin filament bundle(GO:0032432) |
0.7 | 5.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.7 | 16.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.7 | 21.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.7 | 2.8 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.7 | 5.6 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.7 | 0.7 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.7 | 7.7 | GO:0031430 | M band(GO:0031430) |
0.7 | 2.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.7 | 6.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.7 | 0.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.7 | 0.7 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.7 | 43.7 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.7 | 0.7 | GO:0000125 | PCAF complex(GO:0000125) |
0.7 | 2.0 | GO:0043293 | apoptosome(GO:0043293) |
0.7 | 3.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.7 | 3.9 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.6 | 7.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.6 | 2.6 | GO:0045298 | tubulin complex(GO:0045298) |
0.6 | 2.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.6 | 3.2 | GO:0002102 | podosome(GO:0002102) |
0.6 | 10.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.6 | 0.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.6 | 8.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.6 | 2.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.6 | 5.0 | GO:0005861 | troponin complex(GO:0005861) |
0.6 | 5.5 | GO:0042641 | actomyosin(GO:0042641) |
0.6 | 0.6 | GO:0016460 | myosin II complex(GO:0016460) |
0.6 | 2.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.6 | 3.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.6 | 1.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.6 | 3.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.6 | 3.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.6 | 2.9 | GO:0005638 | lamin filament(GO:0005638) |
0.6 | 1.8 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.6 | 4.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.6 | 1.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 1.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.6 | 6.3 | GO:0032039 | integrator complex(GO:0032039) |
0.6 | 1.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.6 | 15.9 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.6 | 3.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.5 | 2.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.5 | 3.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.5 | 0.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.5 | 2.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.5 | 12.4 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.5 | 6.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.5 | 0.5 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.5 | 0.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.5 | 0.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.5 | 27.5 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 1.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.5 | 0.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.5 | 3.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.5 | 1.0 | GO:0033263 | CORVET complex(GO:0033263) |
0.5 | 28.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.5 | 0.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.5 | 1.5 | GO:0005712 | chiasma(GO:0005712) |
0.5 | 0.5 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.5 | 4.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.5 | 2.0 | GO:0070820 | tertiary granule(GO:0070820) |
0.5 | 1.0 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.5 | 9.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.5 | 1.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.5 | 5.5 | GO:0016580 | Sin3 complex(GO:0016580) |
0.5 | 3.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.5 | 4.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.5 | 16.6 | GO:0016592 | mediator complex(GO:0016592) |
0.5 | 0.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.5 | 1.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.5 | 1.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.5 | 1.9 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.5 | 3.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.5 | 1.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.5 | 1.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 3.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.5 | 6.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.5 | 3.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.5 | 5.7 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.5 | 18.2 | GO:0005903 | brush border(GO:0005903) |
0.5 | 12.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.5 | 1.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.5 | 1.4 | GO:0072487 | MSL complex(GO:0072487) |
0.5 | 1.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.5 | 0.5 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.5 | 0.9 | GO:0001739 | sex chromatin(GO:0001739) |
0.5 | 0.5 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.5 | 1.8 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.5 | 3.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 2.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.4 | 2.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 3.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 0.4 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.4 | 0.9 | GO:0033655 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.4 | 2.6 | GO:0038201 | TOR complex(GO:0038201) |
0.4 | 1.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.4 | 1.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.4 | 16.4 | GO:0005776 | autophagosome(GO:0005776) |
0.4 | 2.2 | GO:0033503 | HULC complex(GO:0033503) |
0.4 | 2.6 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.4 | 0.9 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.4 | 1.7 | GO:0000938 | GARP complex(GO:0000938) |
0.4 | 4.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 30.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.4 | 1.7 | GO:0035339 | SPOTS complex(GO:0035339) |
0.4 | 2.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.4 | 1.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.4 | 2.4 | GO:0090543 | Flemming body(GO:0090543) |
0.4 | 101.3 | GO:0005925 | cell-substrate adherens junction(GO:0005924) focal adhesion(GO:0005925) cell-substrate junction(GO:0030055) |
0.4 | 1.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.4 | 0.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.4 | 3.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 6.4 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.4 | 7.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.4 | 2.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.4 | 1.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.4 | 1.2 | GO:0031417 | NatC complex(GO:0031417) |
0.4 | 1.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.4 | 1.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.4 | 5.5 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.4 | 3.9 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.4 | 2.3 | GO:0042599 | lamellar body(GO:0042599) |
0.4 | 1.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.4 | 0.8 | GO:0097452 | GAIT complex(GO:0097452) |
0.4 | 1.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 2.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 16.2 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.4 | 3.0 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.4 | 4.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.4 | 2.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.4 | 1.5 | GO:0030914 | STAGA complex(GO:0030914) |
0.4 | 19.9 | GO:0016605 | PML body(GO:0016605) |
0.4 | 1.5 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.4 | 8.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.4 | 4.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 1.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.4 | 1.5 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.4 | 1.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.4 | 1.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 1.4 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.4 | 9.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.4 | 1.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.4 | 0.7 | GO:0097342 | ripoptosome(GO:0097342) |
0.4 | 1.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.4 | 5.0 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.4 | 6.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.4 | 4.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.4 | 28.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 7.4 | GO:0090544 | BAF-type complex(GO:0090544) |
0.4 | 3.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.0 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 1.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 0.3 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
0.3 | 0.7 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 1.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 2.7 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 3.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.3 | 3.7 | GO:0031672 | A band(GO:0031672) |
0.3 | 2.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 1.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 0.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 6.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.3 | 1.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.3 | 3.0 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 13.9 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.3 | 3.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 8.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.3 | 1.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 1.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 1.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.3 | 1.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 2.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 1.9 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 14.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 1.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.3 | 1.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.3 | 1.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 0.9 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 10.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.3 | 0.9 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 0.9 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 1.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.3 | 10.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 6.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 5.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 0.6 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 3.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 1.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 16.7 | GO:0000922 | spindle pole(GO:0000922) |
0.3 | 1.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 1.2 | GO:0035363 | histone locus body(GO:0035363) |
0.3 | 5.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 1.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.3 | 3.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 0.6 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 92.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.3 | 1.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 0.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 2.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 0.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 10.5 | GO:0044438 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.3 | 3.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 6.5 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.3 | 0.8 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 1.1 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.3 | 1.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 5.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 6.5 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 5.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 1.9 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.3 | 2.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.3 | 0.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 1.6 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.3 | 3.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 0.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 4.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.3 | 8.0 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.3 | 1.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 2.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 6.6 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.3 | 0.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.2 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) |
0.2 | 1.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 2.7 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 0.5 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 8.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 1.0 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 0.7 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 1.7 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 0.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 8.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 5.2 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 0.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.7 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 1.2 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 1.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 0.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.2 | 0.7 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.2 | 13.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 5.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 0.5 | GO:0001939 | female pronucleus(GO:0001939) male pronucleus(GO:0001940) |
0.2 | 7.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 0.5 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 0.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 1.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 1.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 6.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 6.0 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.2 | 0.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 1.1 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.4 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.2 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 1.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 7.6 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 7.9 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 1.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 1.3 | GO:0032797 | SMN complex(GO:0032797) |
0.2 | 1.3 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 1.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 1.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 0.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 2.3 | GO:0005839 | proteasome core complex(GO:0005839) |
0.2 | 2.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 6.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 3.1 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 18.5 | GO:0031965 | nuclear membrane(GO:0031965) |
0.2 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 0.8 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 0.6 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 0.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.2 | 14.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 1.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 8.5 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.2 | 2.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 0.4 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.2 | 23.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.2 | 1.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 15.1 | GO:0000785 | chromatin(GO:0000785) |
0.2 | 178.3 | GO:0005829 | cytosol(GO:0005829) |
0.2 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 1.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 1.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.2 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 1.1 | GO:0031970 | nuclear envelope lumen(GO:0005641) organelle envelope lumen(GO:0031970) |
0.2 | 9.7 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.2 | 1.3 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.2 | 1.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 2.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 2.3 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 1.0 | GO:0000801 | central element(GO:0000801) |
0.2 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.7 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.9 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.2 | 0.5 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 1.4 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.2 | 1.7 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.2 | 4.2 | GO:0030496 | midbody(GO:0030496) |
0.2 | 0.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 0.5 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 6.3 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.2 | 3.5 | GO:1990391 | DNA repair complex(GO:1990391) |
0.2 | 1.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 1.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 0.5 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 0.3 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 154.5 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 6.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 0.6 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 0.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.9 | GO:0000428 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.1 | 5.2 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 20.2 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 3.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 1.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 1.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 1.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 6.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 9.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.1 | 4.0 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.2 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 133.2 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 7.0 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 6.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.8 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.1 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.1 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 42.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 12.8 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.2 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 7.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.4 | GO:0044452 | nucleolar part(GO:0044452) |
0.1 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.5 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 1.6 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 1.4 | GO:0043292 | contractile fiber(GO:0043292) |
0.0 | 3.3 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.5 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 1.0 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 2.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.0 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.0 | 1.6 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.2 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.5 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 1.8 | GO:0005730 | nucleolus(GO:0005730) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.3 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
2.3 | 7.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
2.2 | 2.2 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
2.1 | 8.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.1 | 6.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
2.1 | 6.2 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.0 | 11.9 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
2.0 | 9.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.8 | 5.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.8 | 1.8 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
1.7 | 6.6 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.6 | 4.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.6 | 4.8 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.6 | 4.8 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.5 | 7.7 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.4 | 4.3 | GO:0050692 | DBD domain binding(GO:0050692) |
1.4 | 4.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.4 | 12.8 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.4 | 4.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.4 | 4.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.4 | 4.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.4 | 16.8 | GO:0044548 | S100 protein binding(GO:0044548) |
1.4 | 5.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.3 | 5.4 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.3 | 4.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.3 | 4.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.3 | 5.3 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.3 | 3.9 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.3 | 5.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.3 | 3.9 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.2 | 5.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.2 | 6.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.2 | 8.7 | GO:0018655 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.2 | 3.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.2 | 2.4 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
1.2 | 3.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.2 | 4.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.2 | 8.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.2 | 8.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
1.2 | 3.5 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.2 | 4.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.1 | 10.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
1.1 | 2.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.1 | 13.4 | GO:0017166 | vinculin binding(GO:0017166) |
1.1 | 3.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.1 | 3.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.1 | 7.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.1 | 5.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
1.1 | 8.5 | GO:0008430 | selenium binding(GO:0008430) |
1.1 | 11.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.0 | 4.2 | GO:0045340 | mercury ion binding(GO:0045340) |
1.0 | 6.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.0 | 5.2 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
1.0 | 5.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.0 | 7.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.0 | 2.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.0 | 3.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.0 | 3.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.0 | 1.0 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
1.0 | 6.9 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
1.0 | 2.9 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.0 | 4.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.0 | 2.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.0 | 5.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.0 | 4.8 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
1.0 | 1.9 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
1.0 | 6.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.0 | 3.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.0 | 12.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.9 | 6.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.9 | 1.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.9 | 4.6 | GO:0070061 | fructose binding(GO:0070061) |
0.9 | 4.6 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.9 | 2.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.9 | 2.7 | GO:0004096 | catalase activity(GO:0004096) |
0.9 | 1.8 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.9 | 2.7 | GO:0048030 | disaccharide binding(GO:0048030) |
0.9 | 3.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.9 | 2.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.9 | 5.1 | GO:0015288 | porin activity(GO:0015288) |
0.9 | 3.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.9 | 4.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.8 | 3.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.8 | 0.8 | GO:0034618 | arginine binding(GO:0034618) |
0.8 | 2.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.8 | 3.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.8 | 3.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.8 | 5.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.8 | 2.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.8 | 4.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.8 | 0.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.8 | 0.8 | GO:0036033 | mediator complex binding(GO:0036033) |
0.8 | 4.9 | GO:0043559 | insulin binding(GO:0043559) |
0.8 | 0.8 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.8 | 12.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.8 | 1.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.8 | 2.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.8 | 1.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.8 | 0.8 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.8 | 1.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.8 | 0.8 | GO:0070538 | oleic acid binding(GO:0070538) |
0.8 | 4.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.8 | 3.9 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.8 | 2.4 | GO:0030172 | troponin C binding(GO:0030172) |
0.8 | 8.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.8 | 7.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.8 | 13.9 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.8 | 2.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.8 | 3.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.8 | 3.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.8 | 7.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.8 | 2.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.8 | 0.8 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.8 | 2.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.8 | 3.0 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.8 | 1.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.8 | 6.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.8 | 2.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.7 | 5.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.7 | 2.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.7 | 2.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.7 | 3.7 | GO:0008199 | ferric iron binding(GO:0008199) |
0.7 | 1.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.7 | 2.9 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.7 | 2.2 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.7 | 5.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.7 | 6.5 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.7 | 5.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.7 | 0.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.7 | 5.0 | GO:0046790 | virion binding(GO:0046790) |
0.7 | 15.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.7 | 2.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.7 | 2.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.7 | 13.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.7 | 3.5 | GO:0070728 | leucine binding(GO:0070728) |
0.7 | 0.7 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.7 | 3.5 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.7 | 2.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.7 | 2.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.7 | 7.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.7 | 4.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.7 | 2.1 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.7 | 1.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.7 | 0.7 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.7 | 5.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.7 | 2.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.7 | 2.0 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.7 | 2.7 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.7 | 5.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.7 | 1.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.7 | 1.3 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.7 | 9.4 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.7 | 3.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.7 | 2.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.7 | 2.7 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.7 | 2.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.7 | 2.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.7 | 2.6 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.7 | 3.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.7 | 2.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.7 | 3.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.7 | 4.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 2.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.7 | 9.1 | GO:0008143 | poly(A) binding(GO:0008143) |
0.7 | 3.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.6 | 2.6 | GO:0030984 | kininogen binding(GO:0030984) |
0.6 | 3.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.6 | 1.9 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.6 | 1.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.6 | 5.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.6 | 1.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.6 | 1.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.6 | 1.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.6 | 1.9 | GO:0031013 | troponin I binding(GO:0031013) |
0.6 | 5.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.6 | 5.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.6 | 1.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.6 | 18.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.6 | 3.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.6 | 5.0 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.6 | 1.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.6 | 3.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.6 | 3.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.6 | 2.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.6 | 3.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.6 | 4.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.6 | 2.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.6 | 4.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.6 | 1.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.6 | 1.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.6 | 1.8 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.6 | 1.8 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.6 | 2.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.6 | 0.6 | GO:2001070 | starch binding(GO:2001070) |
0.6 | 1.8 | GO:0005534 | galactose binding(GO:0005534) |
0.6 | 8.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.6 | 2.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.6 | 1.8 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.6 | 2.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.6 | 8.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.6 | 1.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.6 | 5.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.6 | 1.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.6 | 1.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.6 | 18.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.6 | 2.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.6 | 1.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.6 | 4.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.6 | 2.9 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.6 | 2.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.6 | 1.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.6 | 5.1 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.6 | 1.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.6 | 1.7 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.6 | 1.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.6 | 1.7 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.6 | 0.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.6 | 2.8 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.6 | 1.7 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.6 | 7.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.6 | 1.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.6 | 1.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.6 | 0.6 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.6 | 2.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.6 | 4.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.5 | 2.7 | GO:0043426 | MRF binding(GO:0043426) |
0.5 | 2.2 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.5 | 2.2 | GO:0015266 | protein channel activity(GO:0015266) |
0.5 | 0.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.5 | 1.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.5 | 1.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 2.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.5 | 2.2 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.5 | 3.8 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.5 | 3.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.5 | 1.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.5 | 2.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.5 | 2.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.5 | 1.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.5 | 6.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.5 | 3.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.5 | 2.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.5 | 0.5 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.5 | 1.0 | GO:0052849 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.5 | 2.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.5 | 6.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.5 | 3.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.5 | 7.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.5 | 1.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.5 | 3.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.5 | 4.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.5 | 6.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.5 | 1.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.5 | 2.6 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.5 | 16.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.5 | 2.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.5 | 3.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.5 | 5.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.5 | 1.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.5 | 1.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.5 | 5.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.5 | 9.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.5 | 1.5 | GO:0055100 | adiponectin binding(GO:0055100) |
0.5 | 1.5 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.5 | 1.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.5 | 2.0 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.5 | 2.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.5 | 0.5 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.5 | 3.0 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.5 | 1.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.5 | 1.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.5 | 4.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.5 | 3.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.5 | 1.5 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.5 | 7.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.5 | 10.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.5 | 1.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.5 | 2.0 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.5 | 1.5 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.5 | 1.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.5 | 3.4 | GO:0031432 | titin binding(GO:0031432) |
0.5 | 2.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.5 | 2.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.5 | 1.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.5 | 0.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.5 | 0.5 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.5 | 1.4 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 1.0 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.5 | 0.5 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.5 | 0.5 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.5 | 0.9 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.5 | 2.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.5 | 7.0 | GO:0001848 | complement binding(GO:0001848) |
0.5 | 4.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.5 | 1.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.5 | 1.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.5 | 4.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.5 | 0.9 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.5 | 2.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.5 | 1.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.5 | 0.9 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.5 | 2.7 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.5 | 0.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.5 | 5.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.5 | 1.8 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.4 | 1.8 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 0.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.4 | 3.1 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.4 | 7.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.4 | 0.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.4 | 4.5 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.4 | 7.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.4 | 2.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.4 | 0.9 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.4 | 2.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 0.9 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.4 | 6.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.4 | 1.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.4 | 37.6 | GO:0002020 | protease binding(GO:0002020) |
0.4 | 2.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.4 | 4.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.4 | 3.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 8.4 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.4 | 2.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 0.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.4 | 5.9 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.4 | 0.8 | GO:0019862 | IgA binding(GO:0019862) |
0.4 | 4.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.4 | 8.8 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.4 | 0.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 7.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.4 | 1.3 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.4 | 1.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.4 | 12.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.4 | 10.4 | GO:0043826 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.4 | 2.5 | GO:0005536 | glucose binding(GO:0005536) |
0.4 | 21.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.4 | 3.7 | GO:0042469 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.4 | 2.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 2.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.4 | 8.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.4 | 3.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.4 | 1.6 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.4 | 1.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.4 | 1.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.4 | 0.8 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.4 | 6.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 39.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.4 | 1.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 1.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.4 | 5.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.4 | 5.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.4 | 6.0 | GO:0043531 | ADP binding(GO:0043531) |
0.4 | 1.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.4 | 4.0 | GO:0005123 | death receptor binding(GO:0005123) |
0.4 | 2.0 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.4 | 2.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.4 | 1.6 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.4 | 1.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.4 | 2.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.4 | 2.0 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.4 | 1.2 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.4 | 0.8 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.4 | 1.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.4 | 0.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.4 | 3.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 1.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.4 | 3.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 1.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.4 | 3.9 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 0.8 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.4 | 1.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 0.8 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.4 | 1.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.4 | 1.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.4 | 6.9 | GO:0045502 | dynein binding(GO:0045502) |
0.4 | 0.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.4 | 1.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.4 | 2.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 1.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.4 | 0.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.4 | 0.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.4 | 1.9 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.4 | 5.2 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.4 | 5.2 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 0.4 | GO:0008169 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.4 | 1.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 0.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.4 | 0.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.4 | 1.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.4 | 0.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.4 | 4.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.4 | 1.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.4 | 0.7 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.4 | 3.2 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.4 | 2.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 3.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.4 | 10.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.4 | 2.5 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.4 | 1.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 1.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.4 | 1.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.4 | 4.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 1.8 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.4 | 3.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.4 | 1.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.3 | 6.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.3 | 7.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 1.4 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 3.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 4.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.3 | 0.3 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.3 | 4.1 | GO:0005542 | folic acid binding(GO:0005542) |
0.3 | 0.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 2.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.3 | 1.7 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.3 | 2.0 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.3 | 11.1 | GO:0005507 | copper ion binding(GO:0005507) |
0.3 | 1.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 0.3 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 1.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.3 | 1.0 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 7.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 1.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 1.9 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.3 | 1.6 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.3 | 1.6 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.3 | 1.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 1.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.3 | 1.0 | GO:0039706 | co-receptor binding(GO:0039706) |
0.3 | 0.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 0.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.3 | 0.9 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.3 | 1.3 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.3 | 2.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 0.9 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.3 | 0.6 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.3 | 0.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.3 | 2.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 3.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 0.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 1.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.3 | 8.1 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.3 | 5.9 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.3 | 3.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 1.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 2.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 5.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.3 | 6.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.3 | 0.6 | GO:0038100 | nodal binding(GO:0038100) |
0.3 | 0.9 | GO:0009975 | cyclase activity(GO:0009975) |
0.3 | 2.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 1.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 3.0 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.3 | 0.6 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 18.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.3 | 8.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.3 | 4.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 2.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 5.9 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.3 | 1.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 5.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.3 | 2.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 5.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 2.6 | GO:0019841 | retinol binding(GO:0019841) |
0.3 | 1.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 7.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.3 | 2.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.3 | 1.4 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.3 | 0.9 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.3 | 1.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 7.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.3 | 1.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 0.8 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.3 | 1.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.3 | 0.8 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.3 | 3.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.3 | 3.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 0.3 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.3 | 0.6 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.3 | 1.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.3 | 0.6 | GO:0030519 | snoRNP binding(GO:0030519) |
0.3 | 2.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 1.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.3 | 1.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 4.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.3 | 4.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 2.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 2.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.3 | 3.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 0.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.3 | 9.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.3 | 1.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.3 | 3.0 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.3 | 0.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 0.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 0.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 0.8 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 0.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.3 | 22.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.3 | 0.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.3 | 5.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.3 | 1.3 | GO:0052759 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.3 | 2.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.3 | 1.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.3 | 2.3 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.3 | 0.5 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.3 | 1.3 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.3 | 2.8 | GO:0015928 | fucosidase activity(GO:0015928) |
0.3 | 1.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.3 | 0.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.3 | 7.8 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 39.2 | GO:0018169 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.2 | 5.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 0.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 1.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 0.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 2.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 1.5 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 2.0 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.2 | 1.5 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 8.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 1.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 1.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 0.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 1.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 1.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 2.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 1.9 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 2.1 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.2 | 1.0 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 4.3 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.5 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 1.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 4.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 0.9 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.7 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 1.2 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 0.9 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 1.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 2.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 0.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 1.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 6.8 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.2 | 1.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.9 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.2 | 0.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 4.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 0.7 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.2 | 0.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 0.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 4.6 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.2 | 3.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 2.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 1.7 | GO:0032451 | demethylase activity(GO:0032451) |
0.2 | 13.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 0.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 1.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.4 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.2 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 1.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 10.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 11.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 2.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 0.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 1.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 0.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 3.5 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 35.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 2.7 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.2 | 4.7 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 1.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 1.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 0.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 0.2 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 0.6 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 0.8 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 0.6 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 3.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 2.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.2 | 0.6 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.2 | 0.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 2.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 10.4 | GO:0001047 | core promoter binding(GO:0001047) |
0.2 | 0.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 0.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.9 | GO:0016886 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 0.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 2.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.4 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.2 | 3.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.2 | 0.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 2.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 1.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 0.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 1.3 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.2 | 0.4 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.2 | 3.6 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.2 | 1.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 5.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 0.9 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 0.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 7.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 0.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 8.3 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 0.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 2.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 0.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 0.5 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.2 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 0.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 3.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 2.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 2.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 3.0 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.2 | 1.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 0.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 1.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 1.5 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.2 | 0.2 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 0.3 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 2.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 0.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 0.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 3.5 | GO:0018602 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.2 | 3.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 0.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 6.1 | GO:0051020 | GTPase binding(GO:0051020) |
0.2 | 0.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.6 | GO:0004519 | endonuclease activity(GO:0004519) |
0.2 | 0.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 1.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.3 | GO:0045182 | translation regulator activity(GO:0045182) |
0.2 | 0.5 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.2 | 2.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 2.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 1.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.7 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 27.2 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 1.4 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 1.2 | GO:0052688 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 1.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 3.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 4.5 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 5.2 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 1.1 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 6.6 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.1 | 1.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 1.0 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.1 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 1.1 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 0.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.7 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 0.9 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 11.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.7 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 1.9 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 3.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 1.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 1.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 2.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 6.2 | GO:0016791 | phosphatase activity(GO:0016791) |
0.1 | 1.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 17.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.9 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 2.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.2 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 1.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 0.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.1 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 3.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 1.9 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.1 | 0.9 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.1 | 1.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 2.3 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 6.1 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.5 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.2 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 7.8 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 2.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 1.8 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 1.8 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.5 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.1 | 0.1 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 0.8 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.5 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.4 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 4.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 15.6 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 1.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.4 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 1.6 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 38.8 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.3 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 2.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.1 | GO:0051379 | epinephrine binding(GO:0051379) |
0.1 | 0.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.2 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.1 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 2.0 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 9.0 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.3 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 0.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.8 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 1.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.3 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.0 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.3 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 1.7 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.0 | 1.9 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 4.1 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.0 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.4 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 2.2 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.3 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.1 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 3.3 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.2 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.3 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 1.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 13.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 14.2 | ST STAT3 PATHWAY | STAT3 Pathway |
1.2 | 14.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.1 | 16.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.1 | 10.7 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
1.0 | 9.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.0 | 31.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.9 | 2.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.9 | 14.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.9 | 1.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.9 | 1.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.9 | 15.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.9 | 40.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.8 | 44.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.7 | 6.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.7 | 23.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.7 | 13.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.7 | 18.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.7 | 26.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.7 | 9.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.7 | 4.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.7 | 21.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.7 | 8.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.6 | 4.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.6 | 5.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.6 | 20.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.6 | 8.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.6 | 8.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.6 | 21.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.6 | 21.0 | PID P53 REGULATION PATHWAY | p53 pathway |
0.6 | 5.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.5 | 12.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.5 | 9.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.5 | 8.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.5 | 5.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.5 | 6.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.5 | 9.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.5 | 3.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.5 | 5.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.5 | 3.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.5 | 13.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.5 | 6.3 | PID MYC PATHWAY | C-MYC pathway |
0.5 | 13.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.5 | 8.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 4.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.5 | 2.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.5 | 0.5 | ST GAQ PATHWAY | G alpha q Pathway |
0.4 | 1.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.4 | 4.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 2.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.4 | 3.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.4 | 5.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 1.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.4 | 5.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.4 | 2.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.4 | 6.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.4 | 8.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.4 | 2.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.4 | 15.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 3.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 15.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.4 | 5.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.4 | 0.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 12.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.4 | 1.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 3.7 | PID FOXO PATHWAY | FoxO family signaling |
0.4 | 5.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 11.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.4 | 0.7 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.4 | 6.7 | PID ATM PATHWAY | ATM pathway |
0.4 | 3.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 8.0 | PID FGF PATHWAY | FGF signaling pathway |
0.3 | 10.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 4.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 5.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 22.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 6.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 2.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 1.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 8.1 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 5.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 2.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 2.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 4.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 1.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 1.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 4.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 3.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.3 | 0.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 0.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 1.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 1.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 1.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 5.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 1.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 5.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 0.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 2.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 2.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 4.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 1.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 4.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 1.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 3.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 5.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 0.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 5.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 2.9 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 4.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 2.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 3.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 2.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 0.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 1.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 0.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 1.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 0.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 1.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 2.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 1.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 0.4 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 2.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 2.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 1.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 1.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 3.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 13.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 1.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 1.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.2 | PID LKB1 PATHWAY | LKB1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 11.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.4 | 25.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.1 | 14.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.1 | 24.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.1 | 11.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.0 | 11.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.0 | 16.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.0 | 2.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.0 | 6.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.0 | 8.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.9 | 18.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.9 | 9.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.9 | 8.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.9 | 10.9 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.9 | 9.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.9 | 19.7 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.9 | 11.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.9 | 0.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.9 | 2.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.8 | 5.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.8 | 7.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.8 | 6.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.8 | 9.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.8 | 7.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.8 | 7.0 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.8 | 7.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.8 | 12.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.7 | 10.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.7 | 5.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.7 | 7.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.7 | 7.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.7 | 6.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.7 | 8.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.7 | 4.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.7 | 33.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.7 | 7.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.7 | 11.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.7 | 6.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.7 | 0.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.7 | 2.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.6 | 3.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.6 | 6.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.6 | 3.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.6 | 14.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.6 | 25.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.6 | 16.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.6 | 14.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.6 | 6.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.6 | 7.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.6 | 3.0 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.6 | 26.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.6 | 21.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.6 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.6 | 5.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.6 | 0.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.5 | 16.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 13.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.5 | 10.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.5 | 1.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.5 | 0.5 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.5 | 6.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.5 | 2.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.5 | 6.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.5 | 7.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.5 | 8.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.5 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.5 | 14.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.5 | 6.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.5 | 3.5 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.5 | 5.5 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.5 | 3.5 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.5 | 3.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.5 | 2.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.5 | 3.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.5 | 2.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.5 | 1.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.5 | 4.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 10.7 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.5 | 17.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.5 | 3.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.5 | 3.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.5 | 5.9 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.4 | 1.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.4 | 15.7 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.4 | 0.9 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.4 | 3.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.4 | 3.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.4 | 9.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.4 | 1.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 2.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.4 | 0.8 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.4 | 3.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 28.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 5.7 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.4 | 4.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.4 | 4.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 10.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.4 | 7.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.4 | 6.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 26.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 3.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.4 | 10.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.4 | 0.4 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.4 | 25.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.4 | 4.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.4 | 2.7 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.4 | 1.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 0.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 6.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.4 | 7.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.4 | 5.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.4 | 8.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.4 | 3.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.4 | 1.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 7.8 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.4 | 1.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 7.2 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.3 | 1.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.3 | 0.7 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.3 | 4.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.3 | 1.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 1.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 2.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 3.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.3 | 3.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 0.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 14.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 3.5 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.3 | 1.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.3 | 12.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 3.8 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.3 | 2.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.3 | 4.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 4.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.3 | 4.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 0.3 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.3 | 1.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.3 | 9.9 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.3 | 1.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 2.4 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.3 | 4.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 5.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.3 | 2.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.3 | 2.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.3 | 0.6 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 10.2 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.3 | 3.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 6.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.3 | 3.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 1.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 5.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 3.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 1.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.3 | 2.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 22.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 1.8 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.3 | 22.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 2.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 4.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 1.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 2.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 0.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 0.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 9.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 0.2 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.2 | 2.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 0.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 1.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 2.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 1.6 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 3.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 1.9 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 0.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.2 | 8.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 5.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 7.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 0.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 19.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 15.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 4.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 0.5 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.2 | 0.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 10.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 2.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.6 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.1 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 6.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 2.7 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 0.7 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 0.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 3.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 7.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.7 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 2.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.5 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 2.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 1.0 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.8 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 1.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.7 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.7 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 0.1 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.0 | 1.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.0 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.0 | 1.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.1 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.0 | 0.0 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.3 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.0 | 0.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.4 | REACTOME TRANSLATION | Genes involved in Translation |